BX Swiss TOP 30 CHF

BX Swiss TOP 30 CHF handeln
1.493,35 PKT +4,77 PKT +0,32 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN SL0CLV

ISIN DE000SL0CLV3


Analysen zu BX Swiss TOP 30 CHF-Werten

Datum Rating Analyst
20.02.15 Nestlé Hold Kepler Cheuvreux
19.02.15 UBS buy Deutsche Bank AG
19.02.15 Givaudan Neutral Citigroup Corp.
19.02.15 Zurich Insurance Outperform Credit Suisse Group
19.02.15 Swiss Re buy S&P Capital IQ
19.02.15 Nestlé Sell S&P Capital IQ
19.02.15 Holcim buy Deutsche Bank AG
19.02.15 Holcim buy Deutsche Bank AG
19.02.15 Zurich Insurance Neutral JP Morgan Chase & Co.
19.02.15 Holcim Neutral UBS AG
18.02.15 Holcim Strong Sell S&P Capital IQ
17.02.15 UBS Underweight JP Morgan Chase & Co.
17.02.15 UBS overweight JP Morgan Chase & Co.
16.02.15 Zurich Insurance Neutral JP Morgan Chase & Co.
16.02.15 UBS neutral Independent Research GmbH
16.02.15 UBS buy Goldman Sachs Group Inc.
16.02.15 Zurich Insurance Sell Société Générale Group S.A. (SG)
13.02.15 Zurich Insurance Hold S&P Capital IQ
13.02.15 UBS Hold Kepler Cheuvreux
13.02.15 Zurich Insurance neutral Deutsche Bank AG
13.02.15 UBS Underweight JP Morgan Chase & Co.
13.02.15 UBS Neutral UBS AG
12.02.15 UBS buy Deutsche Bank AG
12.02.15 UBS buy S&P Capital IQ
12.02.15 Zurich Insurance Verkaufen DZ-Bank AG
12.02.15 Nestlé Sell Goldman Sachs Group Inc.
12.02.15 Roche overweight Barclays Capital
11.02.15 ABB (Asea Brown Boveri) Neutral Citigroup Corp.
11.02.15 Nestlé Halten Independent Research GmbH
11.02.15 UBS overweight JP Morgan Chase & Co.
11.02.15 Nestlé Neutral UBS AG
11.02.15 UBS buy Kepler Cheuvreux
10.02.15 UBS Halten Independent Research GmbH
10.02.15 UBS buy Kepler Cheuvreux
10.02.15 ABB (Asea Brown Boveri) Neutral UBS AG
10.02.15 ABB (Asea Brown Boveri) Neutral JP Morgan Chase & Co.
09.02.15 Novartis buy Citigroup Corp.
09.02.15 Roche Neutral Citigroup Corp.
09.02.15 Roche overweight JP Morgan Chase & Co.
09.02.15 Nestlé Outperform Bernstein Research